Kennedy Capital Management, Inc. Tela Bio, Inc. Transaction History

Kennedy Capital Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.39 - $6.36 $5,074 - $7,352	-1,156 Reduced 0.3%	381,919 $1.8 Million
Q1 2024 May 15, 2024	BUY	$5.3 - $7.61 $4,563 - $6,552	861 Added 0.23%	383,075 $2.17 Million
Q4 2023 Feb 14, 2024	SELL	$4.5 - $7.51 $24,340 - $40,621	-5,409 Reduced 1.4%	382,214 $2.53 Million
Q3 2023 Nov 14, 2023	BUY	$7.85 - $10.68 $15,393 - $20,943	1,961 Added 0.51%	387,623 $3.1 Million
Q2 2023 Aug 14, 2023	BUY	$9.23 - $11.23 $639,020 - $777,486	69,233 Added 21.88%	385,662 $3.91 Million
Q1 2023 May 15, 2023	BUY	$9.41 - $12.03 $5,231 - $6,688	556 Added 0.18%	316,429 $3.37 Million
Q4 2022 Feb 14, 2023	BUY	$6.5 - $11.5 $2,652 - $4,692	408 Added 0.13%	315,873 $3.63 Million
Q3 2022 Nov 14, 2022	BUY	$7.36 - $9.15 $2.32 Million - $2.89 Million	315,465 New	315,465 $2.69 Million

18.3M

759K

100

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $55.9M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.